2021
Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies
Muniraj T, Aslanian HR, Laine L, Jamidar PA, Farrell JF, Mitchell KA, Salem RR. Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies. World Journal Of Gastroenterology 2021, 27: 1630-1642. PMID: 33958848, PMCID: PMC8058652, DOI: 10.3748/wjg.v27.i15.1630.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdenocarcinoma, MucinousCarcinoma, Pancreatic DuctalHumansPancreatic NeoplasmsPancreatitisRetrospective StudiesConceptsIntra-ductal papillary mucinous neoplasmRecurrent acute pancreatitisPancreatic cystic neoplasmsCystic neoplasmsBD-IPMNAcute pancreatitisCause of pancreatitisRole of resectionMucinous cystic neoplasmPrevalence of malignancyPapillary mucinous neoplasmSerous cystic neoplasmsCross-sectional imagingMean episodesRAP patientsSurgical resectionCyst resectionMD-IPMNPrimary outcomeIPMN patientsRecurrent pancreatitisRetrospective studyCyst featuresGallstone aetiologyMucinous neoplasms
2020
Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance
Chhoda A, Yousaf MN, Madhani K, Aslanian H, Jamidar PA, Suarez AL, Salem R, Muniraj T, Kunstman J, Farrell JJ. Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance. Clinical Gastroenterology And Hepatology 2020, 20: 631-640.e1. PMID: 33309984, DOI: 10.1016/j.cgh.2020.12.008.Peer-Reviewed Original ResearchMeSH KeywordsComorbidityHumansPancreatic CystPancreatic NeoplasmsProspective StudiesRetrospective StudiesConceptsCharlson Comorbidity IndexHigh-risk stigmataMucinous pancreatic cystsOverall mortalityWorrisome featuresPancreatic cystsComorbidity burdenAge-adjusted Charlson comorbidity indexKaplan-Meir survival analysisLow-risk cystsSingle-center studyHigher overall mortalityElectronic medical recordsComorbidity indexProspective surveillanceCenter studyMortality outcomesMedical recordsMucinous cystsPatient outcomesSerial imagingSurveillance populationCohort stratificationSurvival analysisAbstractTextEndoscopic ultrasound (EUS) and the management of pancreatic cancer
Yousaf MN, Chaudhary FS, Ehsan A, Suarez AL, Muniraj T, Jamidar P, Aslanian HR, Farrell JJ. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterology 2020, 7: e000408. PMID: 32414753, PMCID: PMC7232396, DOI: 10.1136/bmjgast-2020-000408.Peer-Reviewed Original ResearchMeSH KeywordsCarcinoma, Pancreatic DuctalCholangiopancreatography, Endoscopic RetrogradeEarly DiagnosisEndosonographyFemaleGastroenterologyHumansInterdisciplinary CommunicationMaleMedical OncologyPancreatic NeoplasmsPatient Care ManagementPrevalenceRadiologyRandomized Controlled Trials as TopicSensitivity and SpecificityStentsSurgical OncologyConceptsManagement of patientsPancreatic cancerEndoscopic ultrasoundIdentification of patientsCancer-related mortalityPancreatic ductal adenocarcinomaSurgical candidatesMedical oncologyPancreatic malignancyDuctal adenocarcinomaRadiological imagingTherapeutic roleSurgical oncologyDiagnostic evaluationEarly diagnosisMultidisciplinary involvementInterventional endoscopyCancerPatientsWestern countriesOncologyManagementAdenocarcinomaMalignancyEndoscopy
2018
Long-Term Follow-Up of Low-Risk Branch Duct IPMNs of the Pancreas: Watch for Main Pancreatic Duct Dilatation, and for How Long?
Muniraj T, Aslanian HR. Long-Term Follow-Up of Low-Risk Branch Duct IPMNs of the Pancreas: Watch for Main Pancreatic Duct Dilatation, and for How Long? Clinical And Translational Gastroenterology 2018, 9: 198. PMID: 30353003, PMCID: PMC6199261, DOI: 10.1038/s41424-018-0065-9.Peer-Reviewed Original Research
2017
Pancreatic Tail Neoplasm Masquerading as Recurrent Splenic Abscesses
Gnanapandithan K, Karthik N, Muniraj T. Pancreatic Tail Neoplasm Masquerading as Recurrent Splenic Abscesses. Journal Of Gastrointestinal Cancer 2017, 49: 507-509. PMID: 28349307, DOI: 10.1007/s12029-017-9938-5.Peer-Reviewed Original Research
2013
Total pancreatectomy and islet autotransplantation in chronic pancreatitis: Recommendations from PancreasFest
Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC, Matthews JB, Amann S, Andersen D, Anderson M, Baillie J, Block G, Brand R, Chari S, Cook M, Cote G, Dunn T, Frulloni L, Greer J, Hollingsworth M, Kim K, Larson A, Lerch M, Lin T, Muniraj T, Robertson R, Sclair S, Singh S, Stopczynski R, Toledo F, Wilcox C, Windsor J, Yadav D. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: Recommendations from PancreasFest. Pancreatology 2013, 14: 27-35. PMID: 24555976, PMCID: PMC4058640, DOI: 10.1016/j.pan.2013.10.009.Peer-Reviewed Original ResearchMeSH KeywordsContraindicationsHumansIslets of Langerhans TransplantationPancreatectomyPancreatic NeoplasmsPancreatitis, ChronicRiskTransplantation, AutologousConceptsChronic pancreatitisIslet autotransplantationTotal pancreatectomyPancreatic cancerQualified multidisciplinary teamHigh-risk patientsSevere diabetes mellitusLong-term managementRisk patientsSevere complicationsDiabetes mellitusSurgical optionsCandidate patientsClinical evaluationMulti-disciplinary teamSurgical proceduresConsensus meetingHigh riskTPIATMultidisciplinary teamNutrition evaluationOptimal timingPancreatitisCareful evaluationPancreatectomyPancreatic neuroendocrine tumors
Muniraj T, Vignesh S, Shetty S, Thiruvengadam S, Aslanian HR. Pancreatic neuroendocrine tumors. Disease-a-Month 2013, 59: 5-19. PMID: 23312533, DOI: 10.1016/j.disamonth.2012.10.002.Peer-Reviewed Original ResearchAngiogenesis InhibitorsBiomarkers, TumorCatheter AblationCryosurgeryDiagnostic ImagingEmbolization, TherapeuticHepatic ArteryHumansLiver TransplantationMultiple Endocrine Neoplasia Type 1Neoadjuvant TherapyNeoplasm GradingNeoplasm StagingNeuroendocrine TumorsPancreatectomyPancreatic NeoplasmsPancreaticoduodenectomyPrognosisRadioisotopesReceptors, PeptideReceptors, Vascular Endothelial Growth FactorSomatostatinTOR Serine-Threonine KinasesWorld Health Organization
2012
Diabetes and pancreatic cancer.
Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterology 2012, 58: 331-45. PMID: 23207610, PMCID: PMC3932318.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody Mass IndexClinical Trials as TopicDiabetes Mellitus, Type 2Early Detection of CancerEvidence-Based MedicineGlobal HealthGlucose IntoleranceHumansHyperinsulinismHypoglycemic AgentsInsulin GlargineInsulin, Long-ActingMeta-Analysis as TopicMetforminObesityPancreatic NeoplasmsPrevalenceRisk AssessmentRisk FactorsConceptsType 2 diabetesNew-onset diabetesPancreatic cancerPancreatic cancer-associated diabetesAnti-diabetic medicationsDuration of diseasePancreatic cancer patientsYears of ageGlucose toleranceCancer patientsOnset diabetesHigh riskEpidemiological studiesDiabetesCancerAdditional markersModest increaseRiskInverse relationshipRecent studiesMedicationsPatientsDisease